A purple and pink letter v on a white background.
October 16, 2014

Venus Concept Launches First Medical Grade Skin Care Line

Introducing Venus Skin™ , the first subscription-based medical grade skincare line that requires no inventory to purchase.

Our business model is unique and made exclusive to physicians, with significant opportunity to increase practice revenue and no upfront financial commitment.

How it Works

Patients make product selections online using an exclusive physician ID code. Each month, the patient will automatically receive a new supply that can be scheduled every 30, 45 and 60 days. Physicians are then sent a monthly commission check based on their sales activity. Physician partners will also benefit from patients who refer friends and family to the program using their exclusive code, thus resulting in increased revenues and a larger patient pool to cross sell other services.

“We have already established a very popular business model with regard to how we offer physicians access to the latest non-surgical technology for body contouring, cellulite reduction and skin tightening via our low risk subscription,” said Domenic Serafino, CEO and Co-Founder of Venus Concept.

“When evaluating potential growth opportunities, we quickly discovered that the medical grade skincare business was another area that was in need of a major overhaul. Traditional skincare companies have spent years discovering ways to sidestep their physician partners by allowing patients to buy their products from third party online outlets at up to 60% discounts. This practice ultimately cuts the physicians out of the profit and many times leaves them with a lot of unsold, expensive inventory with limited expiration dates. With Venus Skin™, we hope to establish a renewed level of trust with our physician partners as our products will never be sold through third party outlets.”

Patient Benefits

Most importantly, Venus Skin™ offers significant benefits to patients. Its unique mix reduces application time to less than 3 minutes per day, yielding visible results in 28 days or less. Our kits include the perfect blend of botanicals featuring Sea Fennel, a clinically proven antioxidant that fights free radicals and protects skin from UV damage.

Future Growth

Initially, Venus Skin™ will offer three kits for patients to choose from: Anti-AgingAcne  and Pigmentation. Over time, the line will expand to include body shaping, cellulite reduction and skin firming formulations to compliment the Venus Freeze™ and Venus Legacy™ technologies. Additionally, the line will feature stem cell based post recovery products for energy based skin rejuvenation treatments.

Unlike with other skincare companies, there is no inventory to purchase or stock with the Venus Skin™ program. Patients make product selections online using an exclusive physician ID code and the order is shipped directly to their homes. Each month, the patient will automatically receive a new 30 day supply of their desired product and all orders are tracked using the physician’s ID code. Physicians are then sent a monthly commission check based on their sales activity. Physician partners will also be able to benefit from patients who refer friends and family to the program using their exclusive ID code, thus resulting in increased revenues and a larger patient pool to cross sell other services.

Venus Skin™ also offers significant benefits to patients. Its unique cocktail formulation reduces application time to less than 3 minutes per day and patients can see results in 28 days or less. Initially, Venus Skin™ will offer three kits for patients to choose from: Anti-Aging, Acne Reduction and Pigmentation Reduction. Over time, the line will expand to include body shaping, cellulite reduction and skin firming formulations to compliment the Venus Freeze™ and Venus Legacy™ technologies. Additionally, the line will feature stem cell based post recovery products for energy based skin rejuvenation treatments.

By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.